Page 4 - Ed Arce News Today

Operator: Greetings. And welcome to the Paratek Pharmaceuticals’ First Quarter 2023 Earnings Conference Call. As a reminder, this conference is being recorded, Tuesday, May 9, 2023.

Operator: Good afternoon, and welcome to Enanta Pharmaceuticals Fiscal Second Quarter Ended March 31, 2022 Financial Results Conference Call. At this time, all participants are in a listen only mode.

Operator: Good day, and thank you for standing by. Welcome to the Akebias First Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.

Operator: Good day, and welcome to the Travere Therapeutics First Quarter 2023 Financial Results and Corporate Update Conference Call. Todays conference is being recorded.

Operator: Greetings and welcome to the DURECT Corporation First Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.

Operator: Greetings, and welcome to Aurinia Pharmaceuticals Inc. First Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.

/PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that Dr. James Brown, President and CEO, will participate in a fireside chat hosted by Ed...

Safety Data From One Trial of New Drug Helpful to Another

HC Wainwright & Co. cut the price target for DURECT Corporation (NASDAQ:DRRX) from $35 to $32. HC Wainwright & Co. analyst Ed Arce maint...

The past two years have been challenging for the biotech sector, based on the market performance of biotech equities. Compared to larger stock market indexes, biotechnology indices underperformed.